Transfection Technologies Market USD 800 Million by 2020, Research Study by iHealthcareAnalyst, Inc.
Maryland Heights, MO, October 22, 2016 --(PR.com)-- The global transfection technologies market is estimated to reach USD 800 Million in 2020, growing at a CAGR of 7.8% from 2016 to 2020, according to a market research report Transfection Technologies Market 2013-2020, published by iHealthcareAnalyst, Inc.
Visit the Transfection Technologies Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/transfection-technologies-market/
The global transfection technologies market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
The global transfection technologies market segmentation is based on transfection methods (instrument based method, electroporation, biolistic technology, microinjection, laserfection, reagent based method, lipid mediated transfection, calcium phosphate, catonic polymers, DEAE-dextran, activated dendrimers, magnetic beads, virus based method), and its applications (biomedical research, transgenic models, cancer research, gene and protein expression studies, cell based microarrays for drug discovery and development, therapeutic delivery, biotherapeutics, electro-chemotherapy and electro-immunotherapy, protein production).
The global transfection technologies market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global transfection technologies market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Transfection Method
1.1. Instrument Based Method
1.1.1.Electroporation
1.1.2. Biolistic Technology
1.1.3. Microinjection
1.1.4. Laserfection
1.2. Reagent Based Method
1.2.1. Lipid Mediated Transfection
1.2.2. Calcium Phosphate
1.2.3. Catonic Polymers
1.2.4. DEAE-Dextran
1.2.5. Activated Dendrimers
1.2.6. Magnetic Beads
1.3. Virus Based Method
2. Application
2.1. Biomedical Research
2.2. Transgenic Models
2.3. Cancer Research
2.4. Gene Expression
2.5. Cell Based Microarrays
2.6. Therapeutics Delivery
2.7. Biotherapeutics
2.8. Electro-Chemo- and Immunotherapy
2.9. Protein Production
3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World
4. Company Profiles
4.1. Bio-Rad Laboratories, Inc.
4.2. Harvard Bioscience, Inc.
4.3. Life Technologies Corporation
4.4. Lonza Group Ltd.
4.5. Merck KGaA
4.6. Mirus Bio LLC
4.7. Polyplus-transfection S.A.
4.8. Promega Corporation
4.9. Qiagen
4.10. Roche Holding AG
4.11. Sigma-Aldrich Corporation
4.12. SignaGen Laboratories
4.13. Thermo Fisher Scientific, Inc.
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Visit the Transfection Technologies Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/transfection-technologies-market/
The global transfection technologies market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
The global transfection technologies market segmentation is based on transfection methods (instrument based method, electroporation, biolistic technology, microinjection, laserfection, reagent based method, lipid mediated transfection, calcium phosphate, catonic polymers, DEAE-dextran, activated dendrimers, magnetic beads, virus based method), and its applications (biomedical research, transgenic models, cancer research, gene and protein expression studies, cell based microarrays for drug discovery and development, therapeutic delivery, biotherapeutics, electro-chemotherapy and electro-immunotherapy, protein production).
The global transfection technologies market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global transfection technologies market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Transfection Method
1.1. Instrument Based Method
1.1.1.Electroporation
1.1.2. Biolistic Technology
1.1.3. Microinjection
1.1.4. Laserfection
1.2. Reagent Based Method
1.2.1. Lipid Mediated Transfection
1.2.2. Calcium Phosphate
1.2.3. Catonic Polymers
1.2.4. DEAE-Dextran
1.2.5. Activated Dendrimers
1.2.6. Magnetic Beads
1.3. Virus Based Method
2. Application
2.1. Biomedical Research
2.2. Transgenic Models
2.3. Cancer Research
2.4. Gene Expression
2.5. Cell Based Microarrays
2.6. Therapeutics Delivery
2.7. Biotherapeutics
2.8. Electro-Chemo- and Immunotherapy
2.9. Protein Production
3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World
4. Company Profiles
4.1. Bio-Rad Laboratories, Inc.
4.2. Harvard Bioscience, Inc.
4.3. Life Technologies Corporation
4.4. Lonza Group Ltd.
4.5. Merck KGaA
4.6. Mirus Bio LLC
4.7. Polyplus-transfection S.A.
4.8. Promega Corporation
4.9. Qiagen
4.10. Roche Holding AG
4.11. Sigma-Aldrich Corporation
4.12. SignaGen Laboratories
4.13. Thermo Fisher Scientific, Inc.
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Contact
Categories